Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Nurix Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +2 vs. Q1 2023
- Shares held
- 43.6M
- +1.16M (+2.7%) vs. Q1 2023
- Total value
- $435.7M
- +$59.1M (+15.7%) vs. Q1 2023
- New holders
- 15
- 45 more added
- Sold out
- 13
- 43 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $2.84B |
| Q1 2026 | 196 | $1.81B |
| Q4 2025 | 182 | $2.15B |
| Q3 2025 | 173 | $783.3M |
| Q2 2025 | 164 | $1.01B |
| Q1 2025 | 170 | $1.01B |
| Q4 2024 | 175 | $1.53B |
| Q3 2024 | 172 | $1.53B |
| Q2 2024 | 174 | $1.36B |
| Q1 2024 | 139 | $721.3M |
| Q4 2023 | 131 | $475.6M |
| Q3 2023 | 129 | $352.5M |
| Q2 2023 | 126 | $435.7M |
| Q1 2023 | 124 | $376.6M |
| Q4 2022 | 119 | $468.6M |
| Q3 2022 | 118 | $561.0M |
| Q2 2022 | 106 | $568.4M |
| Q1 2022 | 117 | $565.6M |
| Q4 2021 | 125 | $1.17B |
| Q3 2021 | 113 | $1.18B |
| Q2 2021 | 104 | $1.05B |
| Q1 2021 | 101 | $1.29B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Nurix Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| WestHill Financial Advisors, Inc. | 283,333 | $2.83M | 0.80% | 00.0% | Unchanged |
| Harvard Management Co Inc | 314,762 | $3.14M | 0.31% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 322,648 | $3.22M | 0.00% | −218,062−40.3% | Reduced |
| Bessemer Group Inc | 357,287 | $3.57M | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 383,959 | $3.84M | 0.00% | −881−0.2% | Reduced |
| FMR LLC | 416,613 | $4.16M | 0.00% | −33,631−7.5% | Reduced |
| Northern Trust Corp | 428,642 | $4.28M | 0.00% | +28,624+7.2% | Added |
| DAFNA Capital Management LLC | 556,695 | $5.56M | 1.52% | −10,000−1.8% | Reduced |
| Bank of America Corp | 588,025 | $5.87M | 0.00% | −43,179−6.8% | Reduced |
| Millennium Management LLC | 644,411 | $6.44M | 0.01% | +182,819+39.6% | Added |
| Nuveen Asset Management, LLC | 667,417 | $6.67M | 0.00% | −2,556−0.4% | Reduced |
| Dimensional Fund Advisors LP | 777,512 | $7.77M | 0.00% | +143,995+22.7% | Added |
| Pictet Asset Management SA | 930,914 | $9.30M | 0.01% | −133,924−12.6% | Reduced |
| Geode Capital Management, LLC | 978,051 | $9.77M | 0.00% | +47,360+5.1% | Added |
| Candriam Luxembourg S.C.A. | 1,019,822 | $10.2M | 0.07% | +119,734+13.3% | Added |
| Boxer Capital, LLC | 1,224,892 | $12.2M | 0.57% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $18.2M | 1.88% | 00.0% | Unchanged |
| State Street Corp | 1,925,726 | $19.2M | 0.00% | −309,552−13.8% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,261,071 | $22.6M | 0.15% | +21,212+0.9% | Added |
| Price T Rowe Associates Inc | 2,379,873 | $23.8M | 0.00% | −204,878−7.9% | Reduced |
| Vanguard Group Inc | 2,692,041 | $26.9M | 0.00% | +68,586+2.6% | Added |
| Redmile Group, LLC | 2,857,309 | $28.5M | 1.10% | +107,925+3.9% | Added |
| Deep Track Capital, LP | 2,997,830 | $29.9M | 1.40% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 3,869,775 | $38.7M | 0.23% | +695,773+21.9% | Added |
| Baker Bros. Advisors LP | 3,882,125 | $38.8M | 0.22% | 00.0% | Unchanged |
| BlackRock Inc. | 4,519,377 | $45.1M | 0.00% | +228,237+5.3% | Added |
| Ergoteles LLC | 0 | $0 | 0.00% | −48,494−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −40,649−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −28,900−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −23,725−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −21,497−100.0% | Sold out |
| BBR Partners, LLC | 0 | $0 | 0.00% | −20,988−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −15,177−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −12,100−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −11,500−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −355−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |